My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 118

    1.

    Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis.

    Penolazzi L, Lampronti I, Borgatti M, Khan MT, Zennaro M, Piva R, Gambari R.

    BMC Complement Altern Med. 2008 Oct 30;8:59.PMID: 18973662 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Apoptosis of human primary osteoclasts treated with molecules targeting nuclear factor-kappaB.

    Piva R, Penolazzi L, Borgatti M, Lampronti I, Lambertini E, Torreggiani E, Gambari R.

    Ann N Y Acad Sci. 2009 Aug;1171:448-56. Review.PMID: 19723088 [PubMed - indexed for MEDLINE]Related articles

    3.

    Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts.

    Penolazzi L, Lambertini E, Borgatti M, Piva R, Cozzani M, Giovannini I, Naccari R, Siciliani G, Gambari R.

    Biochem Pharmacol. 2003 Oct 1;66(7):1189-98.PMID: 14505798 [PubMed - indexed for MEDLINE]Related articles

    4.

    Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.

    Yip KH, Zheng MH, Feng HT, Steer JH, Joyce DA, Xu J.

    J Bone Miner Res. 2004 Nov;19(11):1905-16. Epub 2004 Sep 27.PMID: 15476591 [PubMed - indexed for MEDLINE]Related articles

    5.

    RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.

    Wu X, Pan G, McKenna MA, Zayzafoon M, Xiong WC, McDonald JM.

    J Bone Miner Res. 2005 Jan;20(1):107-16. Epub 2004 Oct 25.PMID: 15619676 [PubMed - indexed for MEDLINE]Related articles

    6.

    Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines.

    Khan MT, Lampronti I, Martello D, Bianchi N, Jabbar S, Choudhuri MS, Datta BK, Gambari R.

    Int J Oncol. 2002 Jul;21(1):187-92.PMID: 12063567 [PubMed - indexed for MEDLINE]Related articles

    7.

    Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.

    Kneissel M, Luong-Nguyen NH, Baptist M, Cortesi R, Zumstein-Mecker S, Kossida S, O'Reilly T, Lane H, Susa M.

    Bone. 2004 Nov;35(5):1144-56.PMID: 15542040 [PubMed - indexed for MEDLINE]Related articles

    8.

    Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.

    Park CK, Kim HJ, Kwak HB, Lee TH, Bang MH, Kim CM, Lee Y, Chung DK, Baek NI, Kim J, Lee ZH, Kim HH.

    Int Immunopharmacol. 2007 Dec 5;7(12):1507-16. Epub 2007 Aug 8.PMID: 17920527 [PubMed - indexed for MEDLINE]Related articles

    9.

    Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1.

    Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M.

    J Cell Biochem. 2004 May 15;92(2):285-95.PMID: 15108355 [PubMed - indexed for MEDLINE]Related articles

    10.

    Human osteoclasts differentiated from umbilical cord blood precursors are less prone to apoptotic stimuli than osteoclasts from peripheral blood.

    Penolazzi L, Pocaterra B, Tavanti E, Lambertini E, Vesce F, Gambari R, Piva R.

    Apoptosis. 2008 Apr;13(4):553-61. Epub 2008 Feb 29.PMID: 18307044 [PubMed - indexed for MEDLINE]Related articles

    11.

    Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.

    Rahman MM, Bhattacharya A, Fernandes G.

    J Lipid Res. 2006 Aug;47(8):1739-48. Epub 2006 May 15.PMID: 16702601 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites.

    Lampronti I, Khan MT, Bianchi N, Ather A, Borgatti M, Vizziello L, Fabbri E, Gambari R.

    Med Chem. 2005 Jul;1(4):327-33.PMID: 16789890 [PubMed - indexed for MEDLINE]Related articles

    13.

    Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitors.

    Van 't Hof RJ, Idris AI, Ridge SA, Dunford J, Greig IR, Ralston SH.

    J Bone Miner Res. 2004 Oct;19(10):1651-60.PMID: 15355560 [PubMed - indexed for MEDLINE]Related articles

    14.

    Zyflamend, a polyherbal preparation, inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of NF-kappa B activation and NF-kappa B-regulated gene products.

    Sandur SK, Ahn KS, Ichikawa H, Sethi G, Shishodia S, Newman RA, Aggarwal BB.

    Nutr Cancer. 2007;57(1):78-87.PMID: 17516865 [PubMed - indexed for MEDLINE]Related articles

    15.

    BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.

    Valverde P, Tu Q, Chen J.

    J Bone Miner Res. 2005 Sep;20(9):1669-79. Epub 2005 May 16.PMID: 16059638 [PubMed - indexed for MEDLINE]Related articles

    16.

    CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.

    Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A, Lisignoli G.

    J Cell Physiol. 2004 May;199(2):244-51.PMID: 15040007 [PubMed - indexed for MEDLINE]Related articles

    17.

    Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.

    Takatsuna H, Asagiri M, Kubota T, Oka K, Osada T, Sugiyama C, Saito H, Aoki K, Ohya K, Takayanagi H, Umezawa K.

    J Bone Miner Res. 2005 Apr;20(4):653-62. Epub 2004 Dec 6.PMID: 15765185 [PubMed - indexed for MEDLINE]Related articles

    18.

    Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.

    Michael H, Härkönen PL, Väänänen HK, Hentunen TA.

    J Bone Miner Res. 2005 Dec;20(12):2224-32. Epub 2005 Aug 1.PMID: 16294275 [PubMed - indexed for MEDLINE]Related articles

    19.

    Regulation of osteoclastogenesis by Simon extracts composed of caffeic acid and related compounds: successful suppression of bone destruction accompanied with adjuvant-induced arthritis in rats.

    Tang QY, Kukita T, Ushijima Y, Kukita A, Nagata K, Sandra F, Watanabe T, Toh K, Okuma Y, Kawasaki S, Rasubala L, Teramachi J, Miyamoto I, Wu Z, Iijima T.

    Histochem Cell Biol. 2006 Mar;125(3):215-25. Epub 2005 Oct 5.PMID: 16205940 [PubMed - indexed for MEDLINE]Related articles

    20.

    The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.

    Urushibara M, Takayanagi H, Koga T, Kim S, Isobe M, Morishita Y, Nakagawa T, Löeffler M, Kodama T, Kurosawa H, Taniguchi T.

    Arthritis Rheum. 2004 Mar;50(3):794-804.PMID: 15022321 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity